ESR1 and breast carcinoma: Thus, while our analysis supports the view that this specific integrative epigenetic-transcriptomic landscape is fairly homogeneous in ER+ breast cancer, this does not by any means exclude the possibility that ER+ breast cancer is highly heterogeneous in relation to the correlative patterns of DNA methylation at distal regulatory elements and downstream gene expression.